Axiom Venture Partners Raise Third
New Fund to Focus on Technology
and Biotechnology Nationwide
Hartford, CT -Axiom Venture
Partners today announced that it has
raised in excess of $100 million to
be invested in young technology and
biotechnology companies nationwide.
This third Axiom Fund, Axiom Venture
Partners III, will follow the successful
model of Axiom I and Axiom II. By
comparison, Axiom II was $58 million
and Axiom I was $44 million in size.
Approximately three-quarters of the
Axiom III funds will be invested in
technology (predominantly information
technology, including communications)
and one-quarter will be invested in
biotechnology. All prior Axiom investors
participated in Axiom III as well
as several notable new investors.
Axiom Limited Partner investors include
large financial institutions (insurance
companies and banks) as well as large
private trusts and several wealthy
entrepreneurs. Learn more about Axiom
This press release is made as a matter
of record, and is not intended, nor
should be interpreted, as a recommendation
or solicitation to invest in any company
or in any Axiom entity.